Free Trial

Nanovibronix (NAOV) Competitors

Nanovibronix logo
$1.01 +0.04 (+3.59%)
Closing price 07/17/2025 04:00 PM Eastern
Extended Trading
$0.98 -0.03 (-2.67%)
As of 07:54 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NAOV vs. NURO, CODX, LFWD, TNON, SINT, POAI, LUCY, STRR, ICU, and STSS

Should you be buying Nanovibronix stock or one of its competitors? The main competitors of Nanovibronix include NeuroMetrix (NURO), Co-Diagnostics (CODX), Lifeward (LFWD), Tenon Medical (TNON), Sintx Technologies (SINT), Predictive Oncology (POAI), Innovative Eyewear (LUCY), Star Equity (STRR), SeaStar Medical (ICU), and Sharps Technology (STSS). These companies are all part of the "medical equipment" industry.

Nanovibronix vs. Its Competitors

Nanovibronix (NASDAQ:NAOV) and NeuroMetrix (NASDAQ:NURO) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, media sentiment, analyst recommendations and profitability.

Nanovibronix has a beta of 1.71, meaning that its share price is 71% more volatile than the S&P 500. Comparatively, NeuroMetrix has a beta of 1.82, meaning that its share price is 82% more volatile than the S&P 500.

Nanovibronix has higher earnings, but lower revenue than NeuroMetrix. NeuroMetrix is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nanovibronix$2.56M1.02-$3.70M-$13.53-0.07
NeuroMetrix$3.03M3.09-$6.53M-$4.59-0.99

16.4% of Nanovibronix shares are held by institutional investors. Comparatively, 19.4% of NeuroMetrix shares are held by institutional investors. 6.3% of Nanovibronix shares are held by company insiders. Comparatively, 7.3% of NeuroMetrix shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Nanovibronix had 1 more articles in the media than NeuroMetrix. MarketBeat recorded 1 mentions for Nanovibronix and 0 mentions for NeuroMetrix. Nanovibronix's average media sentiment score of 0.69 beat NeuroMetrix's score of 0.00 indicating that Nanovibronix is being referred to more favorably in the media.

Company Overall Sentiment
Nanovibronix Positive
NeuroMetrix Neutral

NeuroMetrix has a net margin of -203.71% compared to Nanovibronix's net margin of -210.82%. NeuroMetrix's return on equity of -42.56% beat Nanovibronix's return on equity.

Company Net Margins Return on Equity Return on Assets
Nanovibronix-210.82% -54.73% -38.63%
NeuroMetrix -203.71%-42.56%-39.26%

Summary

NeuroMetrix beats Nanovibronix on 8 of the 13 factors compared between the two stocks.

Get Nanovibronix News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAOV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NAOV vs. The Competition

MetricNanovibronixMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$2.52M$6.58B$5.56B$9.34B
Dividend YieldN/A1.28%3.80%4.06%
P/E Ratio-0.0725.4028.0519.86
Price / Sales1.0263.96446.6499.92
Price / CashN/A20.4535.8457.94
Price / Book0.554.688.275.67
Net Income-$3.70M$174.76M$3.24B$257.80M
7 Day Performance5.35%2.05%1.47%1.86%
1 Month Performance5.81%3.96%8.06%10.91%
1 Year Performance-88.15%5.13%30.37%18.51%

Nanovibronix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAOV
Nanovibronix
0.3213 of 5 stars
$1.01
+3.6%
N/A-88.2%$2.52M$2.56M-0.0720
NURO
NeuroMetrix
N/A$4.55
+4.4%
N/A+23.3%$9.37M$3.03M-0.9920High Trading Volume
CODX
Co-Diagnostics
4.1309 of 5 stars
$0.27
+6.1%
$5.50
+1,973.9%
-78.3%$8.90M$3.91M-0.23100Positive News
High Trading Volume
LFWD
Lifeward
2.7152 of 5 stars
$0.75
+2.9%
$9.00
+1,100.0%
-81.3%$8.26M$25.66M-0.2560
TNON
Tenon Medical
2.0401 of 5 stars
$1.03
+1.0%
$4.67
+353.1%
+62.9%$7.82M$3.28M-0.048
SINT
Sintx Technologies
3.6021 of 5 stars
$2.97
-10.8%
$28.00
+842.8%
-46.4%$7.46M$2.89M-0.0640Positive News
Gap Down
High Trading Volume
POAI
Predictive Oncology
2.4745 of 5 stars
$0.80
+1.3%
$3.00
+275.0%
-33.2%$7.14M$1.62M-0.2630
LUCY
Innovative Eyewear
0.3577 of 5 stars
$2.15
+1.4%
N/A-71.3%$6.66M$1.71M-0.549
STRR
Star Equity
3.637 of 5 stars
$1.96
-2.0%
$5.00
+155.1%
-61.0%$6.29M$57.17M-0.57460Gap Up
ICU
SeaStar Medical
0.4767 of 5 stars
$0.56
-5.3%
N/A-91.4%$6.27M$428K-0.162
STSS
Sharps Technology
0.4373 of 5 stars
$5.87
+2.4%
N/AN/A$5.98MN/A0.003News Coverage

Related Companies and Tools


This page (NASDAQ:NAOV) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners